CERo Therapeutics Holdings, Inc. (CERO)

OQB – Real Time Price. Currency in USD

0.01

-0.00 (-4.55%)

Market open: Aug 12, 2026, 3:58 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-1M

Gross Profit

-1M

Operating expenses (excl. COGS)

-17M

-15M

-7M

-3M

Operating Income

-18M

-16M

-8M

-3M

Non-operating income, total

-1M

385K

Pretax income

-20M

-8M

-7M

-69K

Equity in earnings

Taxes

-599K

Non-controlling/minority interest

After tax other income/expense

-84K

Net income before discontinued operations

-20M

-8M

-7M

-668K

Discontinued operations

Net income

-20M

-8M

-7M

-668K

Dilution adjustment

Preferred dividends

76M

CERo Therapeutics Holdings, Inc. (CERO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

CERo Therapeutics Holdings, Inc. (CERO)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

CERo Therapeutics Holdings, Inc. (CERO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

CERo Therapeutics Holdings, Inc. (CERO)

Income Statement (Annual)

Income Statement (Annual)